How should a ketamine infusion be prepared for status epilepticus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ketamine Infusion Preparation for Status Epilepticus

For refractory status epilepticus, prepare ketamine by diluting to 1-2 mg/mL concentration: transfer 10 mL from a 50 mg/mL vial (or 5 mL from a 100 mg/mL vial) into 500 mL of normal saline or 5% dextrose, then administer as a bolus of 1-2 mg/kg followed by continuous infusion starting at 0.9-1.0 mg/kg/hour, titrating upward every 15 minutes until seizure cessation. 1

Preparation Algorithm

Step 1: Dilution for Infusion

  • Never inject the 100 mg/mL concentration intravenously without dilution 1
  • Standard dilution (1 mg/mL): Aseptically transfer 10 mL from 50 mg/mL vial OR 5 mL from 100 mg/mL vial into 500 mL of either:
    • 0.9% Sodium Chloride (Normal Saline), OR
    • 5% Dextrose in Water 1
  • Concentrated dilution (2 mg/mL): Use 250 mL bag instead of 500 mL when fluid restriction required 1
  • Use immediately after dilution 1
  • Inspect for particulate matter and discoloration before use; discard if present 1

Step 2: Loading Dose Administration

  • Bolus dose: 1-2 mg/kg IV over 1-2 minutes 2, 3
  • Administer slowly to avoid respiratory depression and enhanced vasopressor response 1
  • Have airway equipment immediately available 1

Step 3: Maintenance Infusion

  • Starting rate: 0.9-1.0 mg/kg/hour minimum 2, 3
    • Doses below 0.9 mg/kg/hour are ineffective for seizure control 2, 3
  • Titration: Increase by 1 mg/kg/hour increments every 15 minutes until seizures stop 3
  • Maximum reported doses: Up to 10.5 mg/kg/hour in literature, though typical effective range is 2-3 mg/kg/hour 4, 5
  • Alternative dosing from FDA label: 0.1-0.5 mg/minute (approximately 0.006-0.03 mg/kg/min for 70kg adult) for general anesthesia maintenance 1

Critical Timing Considerations

Initiate ketamine within 3-4 days of status epilepticus onset for optimal efficacy 5, 2:

  • Responders received ketamine at mean 3.2 days vs. 4.3 days for non-responders 5
  • No likely responses observed when ketamine introduced ≥8 days after SE onset 2
  • Earlier administration (within 12 hours) associated with improved seizure control 3

Monitoring Requirements

Continuous monitoring is mandatory 1:

  • Vital signs and cardiac function continuously
  • Oxygen saturation
  • Respiratory status (prepare for bag-valve-mask ventilation or intubation)
  • EEG monitoring to confirm seizure cessation
  • Metabolic acidosis parameters with prolonged infusion 4

Safety Precautions

Pre-Administration

  • Administer antisialagogue prior to induction to manage salivation 1
  • Ensure emergency airway equipment immediately available 1
  • Have benzodiazepines available for emergence reactions 1

During Infusion

  • Respiratory depression risk: 22% transient hypoxia rate reported 6
  • Hemodynamic effects: Monitor for both hypertension and hypotension 1
  • Metabolic acidosis: Particular concern with high-dose, prolonged infusions (>5 days) 4
  • Discontinuation due to adverse events is rare (0.7%) 5

Efficacy Expectations

  • Overall seizure cessation rate: 64% (95% CI 49-76%) 5
  • Permanent control: 57% of episodes 2
  • Pediatric efficacy: 51% seizure cessation 7
  • Mortality reduction: 16% when SE controlled within 24 hours of ketamine initiation vs. 56% when not controlled 2

Common Pitfalls to Avoid

  1. Underdosing: Starting below 0.9 mg/kg/hour is ineffective 2, 3
  2. Delayed initiation: Waiting beyond 8 days significantly reduces efficacy 2
  3. Inadequate dilution: Never give 100 mg/mL concentration IV without dilution 1
  4. Failure to prepare for intubation: Despite ketamine potentially avoiding intubation, 31% may require bag-valve-mask support 6
  5. Premature discontinuation: Average effective infusion duration is 5 days 5

Advantages Over Traditional Anesthetics

  • Avoids intubation: Can be used in general ward settings without ICU transfer 8, 9
  • Shorter ICU stay: 4 days mechanical ventilation vs. 14 days with pentobarbital 10
  • Lower hypotension risk: 42% vs. 77% with barbiturates 10
  • Targets NMDA receptors: Effective when GABA receptor internalization causes benzodiazepine resistance 3

Related Questions

Can the European ketamine dosing recommendations be used for refractory status epilepticus, or are only American guidelines applicable?
Can ketamine be used safely in patients with seizure disorders, and what are the recommended dosing and monitoring guidelines?
What is the KESETT (Ketamine Add‑On Therapy for Established Status Epilepticus Treatment Trial) study?
Is ketamine beneficial for controlling seizures, especially refractory status epilepticus?
What is the preferred agent, etomidate (amidate) or ketamine, for the induction of status epilepticus?
Can I add clomipramine to my as-needed amitriptyline treatment for migraine?
I stopped clonidine on [date] and stopped lurasidone (Latuda) eight weeks ago; I now wake up with panic attacks—how long are these symptoms expected to last?
How can I manage waking panic attacks without medication after stopping clonidine and lurasidone?
In a 63-year-old woman with an 8‑week progressively enlarging verrucous lesion on the nasal bridge that is pruritic but not painful, and a 6‑month history of severe nocturnal lower‑extremity pain (8/10) occurring twice weekly with associated muscle spasms, what is the appropriate diagnostic work‑up and treatment plan for both the skin lesion and the leg pain?
In a COPD patient with pneumonia due to Pseudomonas aeruginosa who has completed a 4‑day IV meropenem course, which oral fluoroquinolone—levofloxacin or ciprofloxacin—is preferred for discharge therapy?
In a cirrhotic patient with new ascites after albumin, is a single 20 mg intravenous furosemide dose potentially harmful?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.